Remacemide Inpatient Seizure Evaluation Trial (RISE)

Leppik, Ilo E.

Abstract

The objective of this contract is to undertake performance of a clinical trial to assess the safety and efficacy of an investigational antiepileptic compound, remacemide, in patients with partial seizures. The Contractor will study 20 patients over a 15 month period.

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Neurological Disorders and Stroke (NINDS)
• Type: Research and Development Contracts (N01)
• Project #: N01NS072337-002005
• Application #: 2321943
• Project Start: 1991-04-15
• Project End: 1993-02-09
• Budget Start: 1992-06-25
• Budget End: 1993-02-09
• Fiscal Year: 1992

Institution

• Name: University of Minnesota Twin Cities
• Department: Neurology
• Type: Schools of Medicine
• DUNS #: 168559177
• City: Minneapolis
• State: MN
• Country: United States
• Zip Code: 55455